文献
J-GLOBAL ID:201802216775277638
整理番号:18A0753154
BRAF V600変異腫瘍患者におけるQTc間隔に対するダブラフェニブと代謝産物の効果の評価【JST・京大機械翻訳】
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600-mutant tumours
著者 (15件):
Nebot Noelia
(Novartis Pharmaceuticals Corporation, East Hanover, NJ, 07936, USA)
,
Arkenau Hendrik-Tobias
(Sarah Cannon Research Institute and University College London, London, W1G 6AD, UK)
,
Infante Jeffrey R.
(Sarah Cannon Research Institute, Nashville, TN, 37203, USA)
,
Chandler Jason C.
(West Cancer Center, Memphis, TN, USA)
,
Weickhardt Andrew
(Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Australia)
,
Lickliter Jason D.
(Nucleus Network, Melbourne, VIC, 3004, Australia)
,
Sarantopoulos John
(Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA)
,
Gordon Michael S.
(Pinnacle Oncology Hematology/HonorHealth Research Institute, Scottsdale, AZ, 85258, USA)
,
Mak Gabriel
(Sarah Cannon Research Institute UK, London, W1G 6AD, UK)
,
St-Pierre Annie
(Novartis Pharma AG, Basel, Switzerland)
,
Tang Lihua
(Novartis Pharmaceuticals Corporation, Morrisville, NC, USA)
,
Mookerjee Bijoyesh
(Novartis Pharmaceuticals Corporation, East Hanover, NJ, 07936, USA)
,
Carson Stanley W.
(Novartis Pharmaceuticals Corporation, Morrisville, NC, USA)
,
Hayes Siobhan
(ICON, Marlow, UK)
,
Grossmann Kenneth F.
(Huntsman Cancer Institute, Salt Lake City, UT, 84112, USA)
資料名:
British Journal of Clinical Pharmacology
(British Journal of Clinical Pharmacology)
巻:
84
号:
4
ページ:
764-775
発行年:
2018年
JST資料番号:
C0957B
ISSN:
0306-5251
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)